164 related articles for article (PubMed ID: 23218442)
1. Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?
Zaorsky NG; Studenski MT; Dicker AP; Gomella L; Den RB
Cancer Treat Rev; 2013 May; 39(3):212-8. PubMed ID: 23218442
[TBL] [Abstract][Full Text] [Related]
2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.
Jabbari S; Weinberg VK; Kaprealian T; Hsu IC; Ma L; Chuang C; Descovich M; Shiao S; Shinohara K; Roach M; Gottschalk AR
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):228-34. PubMed ID: 21183287
[TBL] [Abstract][Full Text] [Related]
5. Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review.
Arcangeli S; Scorsetti M; Alongi F
Crit Rev Oncol Hematol; 2012 Oct; 84(1):101-8. PubMed ID: 22257653
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.
King CR; Brooks JD; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):877-82. PubMed ID: 21300474
[TBL] [Abstract][Full Text] [Related]
7. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
Teh BS; Ishiyama H; Mathews T; Xu B; Butler EB; Mayr NA; Lo SS; Lu JJ; Blanco AI; Paulino AC; Timmerman RD
Discov Med; 2010 Sep; 10(52):255-62. PubMed ID: 20875347
[TBL] [Abstract][Full Text] [Related]
9. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
[TBL] [Abstract][Full Text] [Related]
11. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for prostate cancer.
Ishiyama H; Teh BS; Lo SS; Mathews T; Blanco A; Amato R; Ellis RJ; Mayr NA; Paulino AC; Xu B; Butler BE
Future Oncol; 2011 Sep; 7(9):1077-86. PubMed ID: 21919695
[TBL] [Abstract][Full Text] [Related]
13. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
14. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiation therapy for prostate cancer-a review.
Haque W; Butler EB; Teh BS
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S10. PubMed ID: 28917248
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiation Therapy for Patients with Early-stage Prostate Cancer.
Linney H; Barrett S
Anticancer Res; 2018 Mar; 38(3):1231-1240. PubMed ID: 29491045
[TBL] [Abstract][Full Text] [Related]
18. The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settings.
Khrizman P; Small W; Dawson L; Benson AB
Clin Colorectal Cancer; 2010 Jul; 9(3):136-43. PubMed ID: 20643617
[TBL] [Abstract][Full Text] [Related]
19. A clinical review on extreme hypofractionated stereotactic body radiation therapy for localized prostate cancer using nonrobotic linear accelerators.
Macias VA; Perez-Romasanta LA
Cancer Invest; 2014 Jun; 32(5):191-6. PubMed ID: 24654695
[TBL] [Abstract][Full Text] [Related]
20. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.
Avkshtol V; Dong Y; Hayes SB; Hallman MA; Price RA; Sobczak ML; Horwitz EM; Zaorsky NG
Res Rep Urol; 2016; 8():145-58. PubMed ID: 27574585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
